Cargando…

Progress in atrial fibrillation ablation during 25 years of Europace journal

The first edition of Europace journal in 1999 came right around the time of the landmark publication of the electrophysiologists from Bordeaux, establishing how elimination of ectopic activity from the pulmonary veins (PVs) resulted in a marked reduction of atrial fibrillation (AF). The past 25 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Boersma, Lucas, Andrade, Jason G, Betts, Tim, Duytschaever, Mattias, Pürerfellner, Helmut, Santoro, Francesco, Tzeis, Stylianos, Verma, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451004/
https://www.ncbi.nlm.nih.gov/pubmed/37622592
http://dx.doi.org/10.1093/europace/euad244
_version_ 1785095330906243072
author Boersma, Lucas
Andrade, Jason G
Betts, Tim
Duytschaever, Mattias
Pürerfellner, Helmut
Santoro, Francesco
Tzeis, Stylianos
Verma, Atul
author_facet Boersma, Lucas
Andrade, Jason G
Betts, Tim
Duytschaever, Mattias
Pürerfellner, Helmut
Santoro, Francesco
Tzeis, Stylianos
Verma, Atul
author_sort Boersma, Lucas
collection PubMed
description The first edition of Europace journal in 1999 came right around the time of the landmark publication of the electrophysiologists from Bordeaux, establishing how elimination of ectopic activity from the pulmonary veins (PVs) resulted in a marked reduction of atrial fibrillation (AF). The past 25 years have seen an incredible surge in scientific interest to develop new catheters and energy sources to optimize durability and safety of ablation, as well as study the mechanisms for AF and devise ablation strategies. While ablation in the beginning was performed with classic 4 mm tip catheters that emitted radiofrequency (RF) energy to create tissue lesions, this evolved to using irrigation and contact force (CF) measurement while increasing power. Also, so-called single-shot devices were developed with balloons and arrays to create larger contiguous lesions, and energy sources changed from RF current to cryogenic ablation and more recently pulsed field ablation with electrical current. Although PV ablation has remained the basis for every AF ablation, it was soon recognized that this was not enough to cure all patients, especially those with non-paroxysmal AF. Standardized approaches for additional ablation targets have been used but have not been satisfactory in all patients so far. This led to highly technical mapping systems that are meant to unravel the drivers for the maintenance of AF. In the following sections, the development of energies, strategies, and tools is described with a focus on the contribution of Europace to publish the outcomes of studies that were done during the past 25 years.
format Online
Article
Text
id pubmed-10451004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104510042023-08-26 Progress in atrial fibrillation ablation during 25 years of Europace journal Boersma, Lucas Andrade, Jason G Betts, Tim Duytschaever, Mattias Pürerfellner, Helmut Santoro, Francesco Tzeis, Stylianos Verma, Atul Europace State of the Art Review The first edition of Europace journal in 1999 came right around the time of the landmark publication of the electrophysiologists from Bordeaux, establishing how elimination of ectopic activity from the pulmonary veins (PVs) resulted in a marked reduction of atrial fibrillation (AF). The past 25 years have seen an incredible surge in scientific interest to develop new catheters and energy sources to optimize durability and safety of ablation, as well as study the mechanisms for AF and devise ablation strategies. While ablation in the beginning was performed with classic 4 mm tip catheters that emitted radiofrequency (RF) energy to create tissue lesions, this evolved to using irrigation and contact force (CF) measurement while increasing power. Also, so-called single-shot devices were developed with balloons and arrays to create larger contiguous lesions, and energy sources changed from RF current to cryogenic ablation and more recently pulsed field ablation with electrical current. Although PV ablation has remained the basis for every AF ablation, it was soon recognized that this was not enough to cure all patients, especially those with non-paroxysmal AF. Standardized approaches for additional ablation targets have been used but have not been satisfactory in all patients so far. This led to highly technical mapping systems that are meant to unravel the drivers for the maintenance of AF. In the following sections, the development of energies, strategies, and tools is described with a focus on the contribution of Europace to publish the outcomes of studies that were done during the past 25 years. Oxford University Press 2023-08-25 /pmc/articles/PMC10451004/ /pubmed/37622592 http://dx.doi.org/10.1093/europace/euad244 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle State of the Art Review
Boersma, Lucas
Andrade, Jason G
Betts, Tim
Duytschaever, Mattias
Pürerfellner, Helmut
Santoro, Francesco
Tzeis, Stylianos
Verma, Atul
Progress in atrial fibrillation ablation during 25 years of Europace journal
title Progress in atrial fibrillation ablation during 25 years of Europace journal
title_full Progress in atrial fibrillation ablation during 25 years of Europace journal
title_fullStr Progress in atrial fibrillation ablation during 25 years of Europace journal
title_full_unstemmed Progress in atrial fibrillation ablation during 25 years of Europace journal
title_short Progress in atrial fibrillation ablation during 25 years of Europace journal
title_sort progress in atrial fibrillation ablation during 25 years of europace journal
topic State of the Art Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451004/
https://www.ncbi.nlm.nih.gov/pubmed/37622592
http://dx.doi.org/10.1093/europace/euad244
work_keys_str_mv AT boersmalucas progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT andradejasong progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT bettstim progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT duytschaevermattias progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT purerfellnerhelmut progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT santorofrancesco progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT tzeisstylianos progressinatrialfibrillationablationduring25yearsofeuropacejournal
AT vermaatul progressinatrialfibrillationablationduring25yearsofeuropacejournal